Bluebee

White paper: Bluebee Data security and compliance

Bluebee offers a global bio-informatics platform to process, analyze, share and store genomics data. With a private cloud service, Bluebee supports users in clinical diagnostics, therapeutics and research with advanced analytics for genomic data driven medicine. Designed for cross-functional teams of clinicians and life science researchers the Bluebee platform effectively centralizes and manages genomics data processes and storage. Bluebee’s multi-layered …

Pharma Pricing Congress

Hot topics in pharma and orphan drugs

By Christina Poschen I attended this year’s Pharma Pricing and Market Access Conference in London with attendees across the pharmaceutical industry, payer and HTA bodies and patient representatives. While following the talks, panel discussions and roundtable debates, a few overarching key topics crystallised: –          Germany – AMNOG changes AMNOG, the German pharmaceutical law is regularly adapted to changes in the …

BioPharma Mexico is where experts like Shire Mexico meet to network, learn from each other, and discuss the latest developments in biopharma.

¿Qué Dice Shire Sobre los Medicamentos Huérfanos en México?

Es un placer contar con la participacion de Raúl Vivar, Director General de Shire México, como uno de nuestros ponentes en BioPharma México 2014. Raúl hablará sobre El acceso a instituciones de salud públicas: Una historia de éxito cambiando la vida de pacientes con enfermedades lisosomales, el miércoles, 5 de noviembre a las 16.05 de la tarde. ¡No te lo …

The Stem Cells Regenerative Medicine Congress is where experts like Russell Marians of LABS Inc meet to network, learn from each other, and discuss the latest stem cells strategies and technology.

LABS Inc on ensuring successful scale-up manufacturing

We were glad to have Russell Marians, Senior Scientist and Manager of Molecular and Cellular Biology at LABS Inc., present at the Stem Cells & Regenerative Medicine Congress in 2013. You can now download his presentation slides and video from the event, where he addresses how a winning assay development strategy is critical to ensure successful scale-up manufacturing. Download the presentation …

Stem Cells Regenerative Medicine Congress is where experts like Neuralstem's Richard Garr meet to network, learn from each other, and discuss the latest stem cell strategies and technology.

Neuralstem’s Richard Garr on Optimizing and Increasing Titer

We were excited to have Richard Garr, Chief Executive Officer of Neuralstem, at last year’s Stem Cells Regenerative Medicine Congress. Richard gave a presentation on optimizing and increasing titer in early stage clinical trials for an easier approval process as part of the event that focused on next generation approaches. Other speakers that participated in that section of the event …

BioPharma Mexico es donde van expertos como International Aegerion Pharmaceuticals a conocer al otro, aprender, y discutir las estrategias y tecnologias de la industria biofarmaceutical.

Carolina Alarco de International Aegerion Pharmaceuticals en los Medicamentos Huérfanos

Estábamos felices tener Carolina Alarco, Vicepresidente & Gerente General de International Aegerion Pharmaceuticals, participar en el evento BioPharma Mexico del año pasado. Ahora, se puede descargar su presentación del evento, donde habló sobre las consideraciones para traer un medicamento innovador huérfano a México. Descarga la presentación aquí Carolina Alarco es vicepresidenta y gerente general de Aegerion Pharmaceuticals International. Antes de incorporarse …

Stem Cells USA is where experts like Scimitar Equity's Henry McCusker gather to network, learn from each other, and discuss the latest stem cells strategies and technology.

Scimitar Equity’s Henry McCusker at Stem Cells USA 2013

We were excited to have Scimitar Equity’s Founder and Director of Research Henry McCusker give the opening remarks at last year’s Stem Cells & Regenerative Medicine Congress USA. Henry not only opened up the conference, but also participated in a panel later on in the event. The panel session was titled “Capital formation strategies for stem cell and regenerative medicine …

Pharma M&A AstraZeneca and Pfizer bid of interest

Pharma M&A Games Afoot: Pfizer is interested in AstraZeneca

AstraZeneca’s shares increased 15% on Monday morning, after US drugs giant Pfizer announced its interest in acquiring the UK company. This is the second time the company has approached AstraZeneca within a short time frame. City analyst, Andrew Baum, believed that there was now a 90% chance that Pfizer would achieve its objectives.   Pfizer approached AstraZeneca in January, with …

We were glad to have the FDA share their stem cells and regenerative medicine expertise at Stem Cells USA.

The FDA on regulatory developments in stem cell, cell and gene therapies

Mohammad Heidaran, of the Office of Cellular, Tissue and Gene Therapies, CBER at the FDA, presented at the Stem Cells & Regenerative Medicine Congress in 2013. Enclosed are his presentation slides from the event, where he addresses clarifying aspects like potency assays, purity and identity assessment. You can now view the recording of his presentation alongside these slides, so that …

Download the Provisional Attendee List for the World Stem Cells & Regenerative Medicine Congress 2013

The 8th World Stem Cells & Regenerative Medicine Congress is now only 2 weeks away. We have some great new speakers confirmed, including Tom Okarma, Former President and CEO of Geron Corporation and currently Chief Executive Officer of BioTime Acquisition Corporation. We thought you might like to know which organisations have already confirmed to attend, so that you can see …